x

Pesquisar um projeto de investigação

* (*) campo(s) de preenchimento obrigatório

42 Resultado(s)

Ordenados por

Financiado por um membro do IRDiRC = Membro de uma ERN =

Projetos de investigação

AUSTRIA

STEIERMARK
GRAZ

CRISPR/Cas9 genome engineering to dissect MPN (myeloproliferative neoplasm) pathogenesis
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

ESPANHA

Murcia
EL PALMAR

Financiado por um membro do IRDiRCIdentification of new factors involved in the onset, progression, and complications of Philadelphia-negative chronic myeloproliferative neoplasia
IMIB - Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Grupo de Hematología y Oncología Médica Clínico-Experimental

FRANCA

ILE-DE-FRANCE
PARIS

Physiopathology of human myelofibrosis with myeloid metaplasia
CHU Paris Est - Hôpital Saint-Antoine
UF de cytogénétique onco-hématologique

FRANCA

ILE-DE-FRANCE
VILLEJUIF

Physiopathology of human myelofibrosis with myeloid metaplasia
GHU Paris-Sud - Hôpital Paul Brousse
Les cellules souches: de leurs niches à leurs applications thérapeutiques

ITALIA

EMILIA ROMAGNA
MELDOLA

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ALEMANHA

Mecklenburg-Vorpommern
ROSTOCK

Physical well-being and exercise behavior of patients with myeloproliferative neoplasms (MPN) or mastocytosis
Zentrum für Innere Medizin der Universitätsmedizin Rostock
Klinik III - Hämatologie, Onkologie, Palliativmedizin

AUSTRIA

WIEN
WIEN

Special Research Program - SFB F47 Myleoproliferative Neoplasms
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FINLANDIA

Finland
HELSINKI

Financiado por um membro do IRDiRCMolecular genetics and biology of myeloproliferative neoplasms and other myeloid malignancies
University of Helsinki
Department of Medical and Clinical Genetics

ALEMANHA

Baden-Württemberg
FREIBURG

Financiado por um membro do IRDiRCMyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Pädiatrische Hämatologie und Onkologie

ALEMANHA

Baden-Württemberg
TÜBINGEN

Financiado por um membro do IRDiRCMyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

ALEMANHA

Niedersachsen
HANNOVER

Financiado por um membro do IRDiRCMyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Medizinische Hochschule Hannover
Institut für Humangenetik

ALEMANHA

Nordrhein-Westfalen
DÜSSELDORF

Financiado por um membro do IRDiRCMyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Universitätsklinikum Düsseldorf
Klinik für Kinder-Onkologie, -Hämatologie und klinische Immunologie

ALEMANHA

Sachsen-Anhalt
HALLE (SAALE)

Financiado por um membro do IRDiRCMyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Universitätsklinikum Halle (Saale)
Universitätsklinik und Poliklinik für Pädiatrie I

FRANCA

ILE-DE-FRANCE
FONTENAY-AUX-ROSES CEDEX

Identification by high-throughput functional screens of Fanconi disease modifying genes
DRF/Institut François-Jacob CEA Paris-Saclay
Laboratoire d'Exploration Fonctionnelle des Génomes - LEFG

SUICA

Suisse Alémanique
BERN

Exploiting metabolic liabilities in leukemic stem cells for targeted therapy of myeloid malignancies
University Hospital Inselspital
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor (UKH-HZL)

SUICA

Suisse Alémanique
ZÜRICH

The Swiss Pediatric Hematology/ Oncology Metabank - a network for precision medicine research
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

ALEMANHA

Baden-Württemberg
HEIDELBERG

Financiado por um membro do IRDiRCERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Financiado por um membro do IRDiRCEuropean Reference Network on Paediatric Cancer Connecting Facility 2 - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Financiado por um membro do IRDiRCERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry [PARTNER] - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

CANADA

Ontario
TORONTO

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

FRANCA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALIA

VENETO
PADOVA

Financiado por um membro do IRDiRCModulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

Projetos de investigação multicêntricos